Yoonjung Kim1, Sook Jung Kang2. 1. College of Nursing, Ewha Womans University, Seoul, Republic of Korea. 2. College of Nursing, Ewha Womans University, Seoul, Republic of Korea. sookjungkang@ewha.ac.kr.
Abstract
PURPOSE: This study aimed to review and identify characteristics and lessons learned from studies on computerized cognitive interventions for cancer survivors (CSs) with cognitive dysfunction, exploring the content and results of interventions. METHODS: Studies were collected from the CINAHL, Web of Science, PubMed, and PsycINFO databases. RESULTS: Seven articles that met the inclusion criteria were included. Reviewed studies measured objective cognitive function, subjective cognitive function, and psychological aspects. Computerized interventions for CSs with cognitive decline were effective for executive function, memory, working memory, and speed of thought in the domain of objective cognitive function. Some subjective cognitive functions also showed significant improvement. CONCLUSIONS: Computerized cognitive interventions have a positive impact on objective, subjective, and psychological aspects of cognitive problems. Further research needs to include more men as well as different cancer types. Programs also should include more than one target domain. Future researchers need to develop mobile applications that can effectively use computerized cognitive interventions. IMPLICATIONS FOR CANCER SURVIVORS: Results of this study should help provide optimal approaches to develop and apply effective computerized-cognitive-intervention programs. Health care providers need to be involved in these types of interventions and methods to encourage CSs to proactively practice cognitive-function training need to be developed.
PURPOSE: This study aimed to review and identify characteristics and lessons learned from studies on computerized cognitive interventions for cancer survivors (CSs) with cognitive dysfunction, exploring the content and results of interventions. METHODS: Studies were collected from the CINAHL, Web of Science, PubMed, and PsycINFO databases. RESULTS: Seven articles that met the inclusion criteria were included. Reviewed studies measured objective cognitive function, subjective cognitive function, and psychological aspects. Computerized interventions for CSs with cognitive decline were effective for executive function, memory, working memory, and speed of thought in the domain of objective cognitive function. Some subjective cognitive functions also showed significant improvement. CONCLUSIONS: Computerized cognitive interventions have a positive impact on objective, subjective, and psychological aspects of cognitive problems. Further research needs to include more men as well as different cancer types. Programs also should include more than one target domain. Future researchers need to develop mobile applications that can effectively use computerized cognitive interventions. IMPLICATIONS FOR CANCER SURVIVORS: Results of this study should help provide optimal approaches to develop and apply effective computerized-cognitive-intervention programs. Health care providers need to be involved in these types of interventions and methods to encourage CSs to proactively practice cognitive-function training need to be developed.
Entities:
Keywords:
Cancer survivors; Cognitive function; Computerized cognitive intervention; Systematic review
Authors: David E Vance; Jennifer Sandson Frank; Jennifer Bail; Kristen L Triebel; Lindsay M Niccolai; Adam Gerstenecker; Karen Meneses Journal: Cancer Nurs Date: 2017 Jan/Feb Impact factor: 2.592
Authors: Janette L Vardy; Haryana M Dhillon; Gregory R Pond; Sean B Rourke; Tsegaye Bekele; Corrinne Renton; Anna Dodd; Haibo Zhang; Philip Beale; Stephen Clarke; Ian F Tannock Journal: J Clin Oncol Date: 2015-11-02 Impact factor: 44.544
Authors: Lisa M Hess; Helen Q Huang; Alexandra L Hanlon; William R Robinson; Rhonda Johnson; Setsuko K Chambers; Robert S Mannel; Larry Puls; Susan A Davidson; Michael Method; Shashikant Lele; Laura Havrilesky; Tina Nelson; David S Alberts Journal: Gynecol Oncol Date: 2015-10-09 Impact factor: 5.482